Element Biosciences
Element Biosciences is seeking an experienced Country Manager for Japan to take full ownership of the company's business in the region, driving revenue and market growth for the AVITI system and consumables portfolio. This remote role involves direct territory ownership, strategic account development, and collaboration with channel partners to expand the company's footprint in the life sciences tools market. The ideal candidate will have a strong background in NGS capital equipment sales and multiomic genomics.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2017
Element Biosciences is a genomics and multiomics company that develops sequencing and multiomic platforms, including the AVITI™ family of instruments, consumables, and analysis software. Its flagship AVITI24™ system is the first 5D multiomics platform, enabling spatial and single-cell multiomics, high-quality sequencing, and direct in-sample sequencing (DISS) without library prep. The company serves academic, biotech, pharma, and clinical research customers with accessible, high-quality, and affordable solutions designed to accelerate biological discovery.
Element Biosciences Introduces VITARI™, Redefining What High-Throughput Sequencing Makes Possible
3 weeks ago
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
Nov 11, 2025
Scrappy San Diego startup goes toe-to-toe with gene-sequencing giant Illumina
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Element Biosciences.
Element Biosciences didn’t post a salary, so this is our estimate from similar listings.
biomodal and Element Biosciences Combine Duet Multiomic and High-Throughput Sequencing Capabilities to Advance Clinical Research
2 weeks ago